Alcohol

AvoidCaution

4 studies · 2 recommendations

Last updated: February 25, 2026

Alcohol – Esophageal Cancer
Avoid3 studies

Alcohol consumption directly increases esophageal cancer risk, especially with heavy drinking

Across 3 studies involving over 2,000 participants, alcohol emerges as a confirmed carcinogen for esophageal cancer. IARC classifies alcoholic beverages as a human carcinogen, with esophageal cancer among the 4 most strongly associated tumor sites. A case-control study of 68 esophageal cancer patients and 505 controls found that heavy drinking (42+ drinks per week) acted as a critical co-factor, amplifying cancer risk from other dietary exposures (OR = 2.8). A second case-control study of 395 squamous-cell oesophageal carcinoma cases and 1,066 controls confirmed alcohol as an independent risk factor after adjustment for smoking. Danish population data documented per capita alcohol consumption rising from 4 to 11-12 liters of pure ethanol annually (1955-1990), paralleling increases in alcohol-related diseases. Reducing intake to moderate levels substantially lowers risk, though even moderate daily consumption carries elevated cancer risk.

Evidence

Authors: Altieri, A., Bosetti, C., Conti, E., Dal Maso, L., Franceschi, S., Gallus, S., La Vecchia, C., Levi, F., Negri, E., Zambon, P.

Published: August 2, 2017

In a case-control study of 395 squamous-cell oesophageal carcinoma cases and 1,066 matched controls from Italy and Switzerland (1992-1999), alcohol consumption was controlled as a key confounder in all multivariate analyses. The study explicitly identifies alcohol alongside tobacco as one of the main established risk factors for oesophageal cancer in developed countries. Odds ratios for smoking were computed after adjustment for alcohol consumption, confirming its independent role in upper digestive tract carcinogenesis.

Authors: Barón, Anna E., Bidoli, Ettore, Franceschi, Silvia, La Vecchia, Carlo

Published: August 2, 2017

Among 68 esophageal cancer patients and 505 controls in northeastern Italy, the elevated esophageal cancer risk associated with frequent maize consumption (OR = 2.8, highly significant) was observed exclusively in heavy drinkers consuming 42 or more alcoholic drinks per week. The study population had particularly high levels of alcohol use. This interaction between heavy alcohol consumption and maize-heavy diets, potentially mediated through niacin and riboflavin deficiencies, demonstrates that heavy alcohol use is a critical co-factor in esophageal carcinogenesis in maize-consuming populations.

Authors: Adami, Hans-Olov, Dragsted, Lars, Enig, Bent, Hansen, Jens, Haraldsdóttir, Jóhanna, Hill, Michael J., Holm, Lars Erik, Knudsen, Ib, Larsen, Jens-Jorgen, Lutz, Werner K., Osler, Merete, Overvad, Kim, Sabroe, Svend, Sanner, Tore, Sorensen, Thorkild I. A., Strube, Michael, Thorling, Eivind B.

Published: January 1, 1993

The working group endorsed IARC's classification of alcoholic beverages as a human carcinogen, with esophageal cancer among the 4 most strongly associated tumor sites. Per capita adult alcohol consumption in Denmark rose from 4 liters to 11-12 liters of pure ethanol annually between 1955 and 1990, equating to 2-3 drinks per day. A concomitant increase in acute alcohol-related diseases was documented over this period. The consensus concluded that a substantial proportion of alcohol-induced esophageal cancers results from heavy drinking and that reducing intake to moderate levels should considerably lower risk, while acknowledging that even moderate daily consumption increases cancer risk.

Caution1 studies

Limiting alcohol linked to 18% lower esophageal cancer risk per score point

Alcohol restriction is a component of the WCRF/AICR Cancer Prevention Recommendations. Adherence to these lifestyle guidelines showed a strong protective association with esophageal cancer risk in this large cohort.

Evidence

Authors: Celis-Morales C, Ho FK, Malcomson FC, Mathers JC, Parra-Soto S, Sharp L

Published: January 9, 2024

A prospective study of 288,802 UK Biobank participants cancer-free at baseline (mean age 56.2 years, median follow-up 8.2 years, IQR 7.4–8.9) assessed an abbreviated WCRF/AICR adherence score including alcohol limitation. Each 1-point increment was associated with an 18% reduction in esophageal cancer risk (HR 0.82; 95% CI 0.75–0.90). Among 23,448 total cancer diagnoses, esophageal cancer showed the third-strongest inverse association of nine site-specific cancers. Multivariable Cox proportional hazards models were adjusted for confounders.